EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

Product description

After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.

Read more

Products from other suppliers

EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

Contact information

Address

Telephone

Website

View all contact information
Tjoapack

Tjoapack

Bachem CMC Development and Commercial APIs

Bachem CMC Development and Commercial APIs

Discover Innovation with Softigel by Procaps

Discover Innovation with Softigel by Procaps

Discover The Difference of BD Solutions at Hospital, at Outpatient Clinic and at Home

Discover "The Difference" of BD Solutions at Hospital, at Outp...

Nanoform - an innovative nanoparticle medicine enabling company

Nanoform - an innovative nanoparticle medicine enabling company